Yellow fever vaccination of human immunodeficiency virus-infected patients: report of 2 cases.
Yellow fever vaccine (17D, a live attenuated virus vaccine) was effective and safe in 2 human immunodeficiency virus-infected patients without severe immunosuppression, one of whom traveled to Kenya and the other of whom traveled to Senegal.
Receveur
M C
MC
Department of Internal Medicine, Infectious and Tropical Diseases, Hospital Saint André, Bordeaux, France. marie-catherine. receveur@chu-bordeaux.fr
Thiébaut
R
R
Vedy
S
S
Malvy
D
D
Mercié
P
P
Bras
M L
ML
D000328:Adult; D018791:CD4 Lymphocyte Count; D005260:Female; D015658:HIV Infections / Q000276:immunology / Q000821:virology*; D015497:HIV-1; D006801:Humans; D008297:Male; D015004:Yellow Fever / Q000517:prevention & control*; D022341:Yellow Fever Vaccine / Q000008:administration & dosage*; D015005:Yellow fever virus / Q000276:immunology*
D022341:Yellow Fever Vaccine